RVP (Retractable Technologies) Forward PE Ratio: 0.00 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RVP Retractable Technologies Inc RVP
37 GF Score
Price $0.69
GF Value $0.76
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Retractable Technologies Forward PE Ratio?

Retractable Technologies RVP +0.03% 37 Forward PE Ratio is 0.00 as of Jul. 15, 2026. GuruFocus rates RVP with a GF Score™ of 37/100 and a GF Value™ of $0.76 (Fairly Valued). The stock has 3 warning signs investors should review. Among 392 Medical Devices & Instruments companies, Retractable Technologies ranks worse than 255101.79% on this metric.

Retractable Technologies's Forward PE Ratio for today is 0.00.

Retractable Technologies's PE Ratio without NRI for today is 0.00.

Retractable Technologies's PE Ratio (TTM) for today is 0.00.


Retractable Technologies  (AMEX:RVP) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Retractable Technologies Forward PE Ratio Related Terms


Retractable Technologies Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for Retractable Technologies's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Retractable Technologies Forward PE Ratio Chart

Retractable Technologies Annual Data
Trend
Forward PE Ratio

Retractable Technologies Quarterly Data
Forward PE Ratio

RVP vs ZJYL, HBIO, RGNT: Forward PE Ratio Comparison

For the Medical Instruments & Supplies subindustry, Retractable Technologies's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Retractable Technologies Forward PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Retractable Technologies's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Retractable Technologies's Forward PE Ratio falls into.


RVP
37GF Score
Retractable Technologies Inc RVP
Forward PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Retractable Technologies Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 0.00 mean?
Retractable Technologies (RVP) has a Forward PE Ratio of 0.00 as of Jul. 15, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Retractable Technologies and its competitors. According to the industry distribution chart, Retractable Technologies ranks #999999 out of 392 companies in the Medical Devices & Instruments industry.
Is Retractable Technologies' Forward PE Ratio too high?
Retractable Technologies' current Forward PE Ratio is 0.00. Based on the distribution chart, Retractable Technologies ranks #999999 out of 392 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Retractable Technologies has a GF Score™ of 37/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Retractable Technologies' Forward PE Ratio compare to ZJYL and HBIO?
According to the Medical Devices & Instruments industry distribution chart, Retractable Technologies ranks #999999 out of 392 companies for Forward PE Ratio. This places Retractable Technologies in the lower half of its industry. The industry median Forward PE Ratio is 19.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Devices & Instruments company?
The median Forward PE Ratio among Medical Devices & Instruments companies is 19.35, based on 392 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Retractable Technologies and its competitors. For the Medical Devices & Instruments industry, the median Forward PE Ratio is 19.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Retractable Technologies's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Retractable Technologies stock overvalued right now?
Based on GuruFocus' analysis, Retractable Technologies (RVP) is currently considered Fairly Valued. The stock's GF Value™ is $0.76, compared to a current price of $0.69 — trading 9.2% below its estimated fair value. The current Forward PE Ratio is 0.00. Retractable Technologies' overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Retractable Technologies (RVP), the current Forward PE Ratio is 0.00 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Retractable Technologies (RVP) Overvalued in 2026?

Based on GuruFocus' analysis, Retractable Technologies stock appears to be undervalued. The current stock price of $0.69 is trading 9.2% below its estimated GF Value™ of $0.76. GuruFocus considers Retractable Technologies to be Fairly Valued.

Key valuation signals for RVP:

  • Forward PE Ratio: 0.00
  • GF Value™: $0.76 vs. price of $0.69 (9.2% below fair value)
  • GF Score™: 37/100 with 3 warning signs

No single metric tells the full story. See the RVP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Retractable Technologies Business Description

Address 511 Lobo Lane, Little Elm, TX, USA, 75068-5295
Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.
37GF Score

Get the complete analysis for RVP

Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.69
Price
$0.76
GF Value